Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces

Information

  • Research Project
  • 10213281
  • ApplicationId
    10213281
  • Core Project Number
    U18FD007244
  • Full Project Number
    1U18FD007244-01
  • Serial Number
    007244
  • FOA Number
    PAR-18-604
  • Sub Project Id
  • Project Start Date
    9/20/2020 - 4 years ago
  • Project End Date
    8/31/2025 - 6 months from now
  • Program Officer Name
    CERIC, OLGICA
  • Budget Start Date
    9/20/2020 - 4 years ago
  • Budget End Date
    8/31/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/21/2020 - 4 years ago
Organizations

Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces

Project Summary/Abstract As a part of the FDA Veterinary Laboratory Information Response Network (Vet-LIRN) initiative ?to support enhanced human and animal food safety? Animal Health Laboratory (AHL) acquired MiSeq Illumina and was tasked to established a Canadian veterinary diagnostics laboratory unit (5 source labs and 1 WGS regional lab) to support and expand Vet-LIRN's Antimicrobial Resistance-Whole Genome Sequencing (AMR-WGS) program. This unit was established in 2018 and the program ran throughout 2019 with bacterial isolates (604), metadata and antimicrobial susceptibility results collection and whole genome sequencing (WGS) of selected isolates (270). The isolate collection slowed down in the second quarter of 2020 because of COVID-19, and also one laboratory dropped out of the program due to a staffing shortage. As a result, our objectives for this multiyear project are: 1. To recruit another source laboratory for isolate, metadata and antimicrobial susceptibility results collection for 2021. 2. To continue established collaboration with other source laboratories by providing them with supplies and covering quarterly shipping expenses for isolates and data collection. 3. To continue with isolates collection at AHL. 4. To increase surge capacity and capability of AHL in order to aid Vet-LIRN AMR surveillance efforts and clinical disease investigations using harmonized methodology by: a. Using Illumina MiSeq to do WGS of bacterial isolates following protocols provided by Vet-LIRN. b. Participating in proficiency testing provided by GenomeTrakr. c. Submitting sequence information to NCBI to make them publicly available.

IC Name
FOOD AND DRUG ADMINISTRATION
  • Activity
    U18
  • Administering IC
    FD
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    62823
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    103
  • Ed Inst. Type
  • Funding ICs
    FDA:62823\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZFD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF GUELPH
  • Organization Department
  • Organization DUNS
    208472209
  • Organization City
    GUELPH
  • Organization State
    ON
  • Organization Country
    CANADA
  • Organization Zip Code
    N1G 2W1
  • Organization District
    CANADA